EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 26 srpnja 2024. Database contains 4821 unique substances/entries.
Filter the list
|
618-004-1
|
87392-12-9
|
Skin Sens. 1 |
|||
|
617-100-0
|
8051-02-3
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
202-345-4
|
94-59-7
|
Carc. 1B; Muta. 2; Acute Tox. 4 |
|||
|
200-712-3
|
69-72-7
|
Repr. 2; Acute Tox. 4; Eye Dam. 1 |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
68583-35-7
|
B Bacteria and similar species |
|||
|
425-210-3
|
169939-84-8
|
Skin Sens. 1 |
|||
|
-
|
-
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
-
|
-
|
Acute Tox. 3 |
|||
|
-
|
-
|
Acute Tox. 3 |
|||
|
show/hide
2-sec-butyl-4,6-dinitrophenol, compound with 1-aminopropan-2-ol (1:1)
EC / List no:
275-931-0
| CAS no:
71735-19-8
2-sec-butyl-4,6-dinitrophenol, compound with 2,2'-iminodiethanol (1:1)
EC / List no:
258-532-6
| CAS no:
53404-43-6
2-sec-butyl-4,6-dinitrophenol, compound with 2,2',2''-nitrilotriethanol (1:1)
EC / List no:
229-166-4
| CAS no:
6420-47-9
|
-
|
-
|
Repr. 1B; Acute Tox. 3; Eye Irrit. 2 |
||
|
show/hide
|
-
|
-
|
Repr. 1B; Acute Tox. 2; Acute Tox. 3 |
||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
|||
|
show/hide
Acetic acid, (2,4-dichlorophenoxy)-, compd. with 2-[2-[2-(octadecylamino)ethoxy]ethoxy]ethanol(1:1)
EC / List no:
-
| CAS no:
37937-04-5
Tris(2-hydroxyethyl)ammonium (o,p-dichlorophenoxy)acetate
EC / List no:
219-911-1
| CAS no:
2569-01-9
1-[bis(2-hydroxypropyl)amino]propan-2-ol;2-(2,4-dichlorophenoxy)acetic acid
EC / List no:
639-766-1
| CAS no:
18584-79-7
|
-
|
-
|
Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
||
|
-
|
-
|
Acute Tox. 4; Eye Dam. 1 |
|||
|
209-030-0
|
553-00-4
|
Carc. 1A; Acute Tox. 4 |
|||
|
210-313-6
|
612-52-2
|
Carc. 1A; Acute Tox. 4 |
|||
|
-
|
-
|
Carc. 1B; Acute Tox. 4; Skin Sens. 1 |
|||
|
show/hide
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-38-8
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(2-hydroxy-3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-49-1
(1,1'-Biphenyl)-4,4'-diamine, 3,3'-dimethoxy-, monohydrochloride
EC / List no:
-
| CAS no:
111984-09-9
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(2-hydroxy-3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-48-0
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-53-7
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
||
|
265-294-7
|
64969-36-4
|
Carc. 1B; Acute Tox. 4 |
|||
|
210-322-5
|
612-82-8
|
Carc. 1B; Acute Tox. 4 |
|||
|
277-985-0
|
74753-18-7
|
Carc. 1B; Acute Tox. 4 |
|||
|
show/hide
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, 2-hydroxyethanesulfonate
EC / List no:
-
| CAS no:
86157-51-9
4,4'-bis[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo][1,1'-biphenyl]-2,2'-disulphonic acid, compound with 4,4'-carbonimidoylbis[N,N-dimethylphenylamine] (1:2)
EC / List no:
277-106-0
| CAS no:
72939-51-6
Benzenesulfonic acid, 4-dodecyl-, compd. with 4,4'-carbonimidoylbis(N,N-dimethylbenzenamine) (1:1)
EC / List no:
-
| CAS no:
63589-43-5
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, (2-methoxyethoxy)acetate
EC / List no:
-
| CAS no:
82941-28-4
Decyl hydrogen sulphate, compound with 4,4'-carbonimidoylbis[N,N-dimethylaniline] (1:1)
EC / List no:
281-828-1
| CAS no:
84030-53-5
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, mono(dodecylbenzenesulfonate)
EC / List no:
-
| CAS no:
82794-01-2
Methanaminium, N-(4-(amino(4-(dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, dodecyl(sulfophenoxy)benzenesulfonate (2:1)
EC / List no:
-
| CAS no:
63428-09-1
4,4'-carbonimidoylbis(N,N-dimethylaniline) monohydrochloride
EC / List no:
219-567-2
| CAS no:
2465-27-2
|
-
|
-
|
Carc. 2; Acute Tox. 4; Eye Irrit. 2 |
||
|
-
|
-
|
Acute Tox. 2 |
|||
|
show/hide
Benzenesulfonic acid, 2(or 4)-methyl-, compd. with benzenamine (1:1)
EC / List no:
-
| CAS no:
70788-38-4
Benzenesulfonic acid, 2,2'-dithiobis(5-methyl-, compd. with benzenamine (1:2)
EC / List no:
-
| CAS no:
63468-80-4
|
-
|
-
|
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1 |
||
|
-
|
-
|
Acute Tox. 2 |
|||
|
208-520-1
|
531-86-2
|
Carc. 1A; Acute Tox. 4 |
|||
|
208-519-6
|
531-85-1
|
Carc. 1A; Acute Tox. 4 |
|||
|
252-984-8
|
36341-27-2
|
Carc. 1A; Acute Tox. 4 |
|||
|
244-236-4
|
21136-70-9
|
Carc. 1A; Acute Tox. 4 |
|||
|
-
|
-
|
Carc. 1A; Acute Tox. 4 |
|||
|
show/hide
|
-
|
-
|
Repr. 2; Acute Tox. 2; Acute Tox. 3; Skin Sens. 1 |
||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
Acute Tox. 3; STOT RE 2 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
show/hide
1,2,4-triazolidine-3,5-dione, compound with hydrazine (1:1)
EC / List no:
264-246-2
| CAS no:
63467-96-9
|
-
|
-
|
Carc. 1B; Acute Tox. 3; Skin Sens. 1 |
||
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1 |
|||
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1 |
|||
|
-
|
-
|
Acute Tox. 2 |
|||
|
show/hide
|
-
|
-
|
Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2 |
||
|
-
|
-
|
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
Acute Tox. 2 |
|||
|
-
|
-
|
Unst. Expl.; Acute Tox. 3 |
|||
|
-
|
-
|
Acute Tox. 2 |
|||
|
-
|
-
|
Acute Tox. 2 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
205-801-0
|
152-16-9
|
Acute Tox. 1; Acute Tox. 2 |
|||
|
203-300-1
|
105-46-4
|
Flam. Liq. 2 |
|||
|
213-104-8
|
924-43-6
|
Flam. Liq. 2; Acute Tox. 4 |
|||
|
611-802-0
|
591-34-4
|
Flam. Liq. 3 |
|||
|
237-732-7
|
13952-84-6
|
Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A |
|||
|
247-554-1
|
26259-45-0
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
231-957-4
|
7782-49-2
|
Acute Tox. 3; STOT RE 2 |
|||
|
show/hide
Ethyl 3-ethyl-2-[5-(3-ethyl-3H-benzoselenazol-2-ylidene)penta-1,3-dienyl]benzoselenazolium sulphate
EC / List no:
213-583-3
| CAS no:
988-93-2
Hydrogen 2-[2-methyl-3-[3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]prop-1-enyl]-3-(3-sulphonatopropyl)benzoselenazolium
EC / List no:
258-101-2
| CAS no:
52685-95-7
3-ethyl-2-[3-(3-ethyl-5,6-dimethyl-3H-benzoselenazol-2-ylidene)-2-methylprop-1-enyl]-5,6-dimethylbenzoselenazolium bromide
EC / List no:
257-428-8
| CAS no:
51799-69-0
3-ethyl-2-[2-[(3-ethyl-5-methoxy-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]-6-methylbenzothiazolium iodide
EC / List no:
264-494-1
| CAS no:
63816-16-0
N,N,6-triethyl-5-thioxo-2,4-dithia-3-selena-6-azaoctanethioamide
EC / List no:
205-267-9
| CAS no:
136-92-5
2-[3-(3-ethyl-5-methoxybenzoselenazol-2(3H)-ylidene)-2-(thien-2-yl)prop-1-enyl]-3-(2-hydroxyethyl)-6-methoxy-5-methylbenzothiazolium bromide
EC / List no:
270-563-7
| CAS no:
68443-89-0
Quinolinium, 1-butyl-4-(3-(3-ethyl-2(3H)-benzoselenazolylidene)-1-propen-1-yl)-, iodide (1:1)
EC / List no:
-
| CAS no:
65294-08-8
3-(3-Sulfopropyl)-2-((3-(3-sulfopropyl)-2(3H)-benzoselenazolylidene)methyl)benzoselenazolium, hydroxide, inner salt, sodium salt
EC / List no:
-
| CAS no:
55425-27-9
3-ethyl-2-[2-[[5-methoxy-3-(4-sulphonatobutyl)benzoselenazol-2(3H)-ylidene]methyl]but-1-enyl]-5,6-dimethylbenzothiazolium
EC / List no:
285-276-2
| CAS no:
85050-03-9
Cadmium selenide (CdSe), solid soln. with cadmium sulfide, zinc selenide and zinc sulfide, europium-doped
EC / List no:
309-899-7
| CAS no:
101357-02-2
Hydrogen-2-[2-[[5-methoxy-3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]methyl]but-1-enyl]-5,6-dimethyl-3-(3-sulphonatopropyl)benzothiazolium
EC / List no:
246-411-0
| CAS no:
24687-35-2
Bis(diethylthiocarbamato-S)bis(diethylthiocarbamato-S,S')selenium
EC / List no:
244-442-4
| CAS no:
21559-14-8
3-ethyl-2-[3-(3-ethyl-3H-benzoselenazol-2-ylidene)prop-1-enyl]benzoxazolium iodide
EC / List no:
251-249-9
| CAS no:
32835-25-9
3-ethyl-5,6-dimethyl-2-[2-[[5-methyl-3-(2-methyl-3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]methyl]but-1-enyl]benzothiazolium
EC / List no:
303-101-0
| CAS no:
94158-30-2
Cadmium selenide (CdSe), solid soln. with cadmium sulfide, zinc selenide and zinc sulfide, copper and manganese-doped
EC / List no:
309-898-1
| CAS no:
101357-01-1
1-ethyl-2-[3-(3-ethyl-3H-benzoselenazol-2-ylidene)prop-1-enyl]quinolinium iodide
EC / List no:
276-697-2
| CAS no:
72491-44-2
1-benzyl-6-methoxy-2-[[3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]methyl]quinolinium
EC / List no:
264-488-9
| CAS no:
63816-07-9
5-chloro-3-ethyl-2-[2-[[5-methoxy-3-(4-sulphonatobutyl)benzoselenazol-2(3H)-ylidene]methyl]but-1-enyl]benzothiazolium
EC / List no:
264-558-9
| CAS no:
63907-45-9
3-(2-carboxyethyl)-2-[2-[[3-(2-carboxyethyl)-5-methyl-(3H)-benzoselenazol-2-ylidene]methyl]but-1-enyl]-5-methylbenzoselenazolium bromide
EC / List no:
289-516-7
| CAS no:
89703-05-9
5-ethoxy-2-[2-[(3-ethyl-5-methyl-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]-3-(3-sulphonatopropyl)benzothiazolium
EC / List no:
259-833-5
| CAS no:
55811-25-1
2-(4,5-dimethyl-2H-1,3-diselenol-2-ylidene)-4,5-dimethyl-2H-1,3-diselenole
EC / List no:
623-491-9
| CAS no:
55259-49-9
Benzothiazolium, 3-(2-carboxyethyl)-2-(2-((3-ethyl-5-methoxy-2(3H)-benzoselenazolylidene)methyl)-1-buten-1-yl)-6-methoxy-5-methyl-, iodide (1:1)
EC / List no:
-
| CAS no:
70942-37-9
1-benzyl-6-methoxy-2-[[3-(4-sulphonatobutyl)-3H-benzoselenazol-2-ylidene]methyl]quinolinium
EC / List no:
264-475-8
| CAS no:
63815-75-8
2-[2-[[5,6-dimethyl-3-(4-sulphonatobutyl)-3H-benzoselenazol-2-ylidene]methyl]-1-butenyl]-1-ethylnaphtho[1,2-d]thiazolium
EC / List no:
303-714-3
| CAS no:
94213-13-5
1-ethyl-6-methoxy-2-[[5-methoxy-3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]methyl]quinolinium
EC / List no:
241-805-9
| CAS no:
17852-69-6
2-[2-[(3-ethyl-5-methylbenzoselenazol-2(3H)-ylidene)methyl]but-1-enyl]-5,6-dimethyl-3-(3-sulphonatopropyl)benzothiazolium
EC / List no:
280-796-6
| CAS no:
83783-61-3
3-(2-carboxyethyl)-2-[2-[[3-(2-carboxyethyl)-(3H)-benzoselenazol-2-ylidene]methyl]but-1-enyl]-5-methylbenzoselenazolium bromide
EC / List no:
272-157-5
| CAS no:
68758-81-6
2-[2-[(3-ethyl-5-methoxy-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]-6-methoxy-5-methyl-3-(4-sulphonatobutyl)benzothiazolium
EC / List no:
264-472-1
| CAS no:
63815-64-5
3-ethyl-2-[3-(3-ethyl-5-methoxy-3H-benzoselenazol-2-ylidene)prop-1-enyl]-5-methoxybenzoselenazolium iodide
EC / List no:
298-770-8
| CAS no:
93838-99-4
3-methyl-5-phenyl-2-[2-[[3-(3-sulphonatobutyl)-3H-benzoselenazol-2-ylidene]methyl]but-1-enyl]benzoxazolium
EC / List no:
278-389-3
| CAS no:
76213-48-4
Hydrogen 2-[2-[[5,6-dimethyl-3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]methyl]but-1-enyl]-5,6-dimethyl-3-(3-sulphonatopropyl)benzoselenazolium, sodium salt
EC / List no:
257-984-1
| CAS no:
52513-84-5
2-[3-[6-methoxy-5-methyl-3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]-2-(methylthio)-1-propenyl]-1-methylnaphtho[1,2-d]thiazolium
EC / List no:
303-336-9
| CAS no:
94166-40-2
Cadmium selenide (CdSe), solid soln. with cadmium sulfide, zinc selenide and zinc sulfide, aluminum and copper-doped
EC / List no:
309-897-6
| CAS no:
101357-00-0
1-ethyl-2-[(3-ethyl-5-methoxy-3H-benzoselenazol-2-ylidene)methyl]-6-methoxyquinolinium iodide
EC / List no:
256-566-6
| CAS no:
50378-83-1
3-ethyl-2-[2-[(3-ethyl-5-methoxy-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]-5-methoxybenzoselenazolium iodide
EC / List no:
271-426-4
| CAS no:
68555-40-8
3-ethyl-2-[3-(3-ethyl-3H-benzoselenazol-2-ylidene)prop-1-enyl]benzothiazolium iodide
EC / List no:
251-252-5
| CAS no:
32835-32-8
2-[2-[[5,6-dimethoxy-3-(3-sulphonatopropyl)-(3H)-benzoselenazol-2-ylidene]methyl]but-1-enyl]-3-ethyl-5,6-dimethylbenzoselenazolium
EC / List no:
252-595-3
| CAS no:
35498-95-4
1-ethyl-2-[(3-ethyl-5-methoxy-2(3H)-benzoselenazolylidene)methyl]-6-methoxyquinolinium bromide
EC / List no:
267-113-7
| CAS no:
67800-88-8
Cadmium selenide (CdSe), solid soln. with cadmium sulfide, zinc selenide and zinc sulfide, manganese and silver-doped
EC / List no:
309-901-6
| CAS no:
101357-04-4
Benzothiazolium, 2-(2-((3-ethyl-5-methoxy-2(3H)-benzoselenazolylidene)methyl)-1-buten-1-yl)-6-methoxy-5-methyl-3-(3-sulfopropyl)-, inner salt
EC / List no:
-
| CAS no:
63815-98-5
Residues, zinc refining flue dust wastewater, mercury-selenium
The hot gases obtained by the roasting of raw zinc concentrate are cooled and cleaned from dust by passing through a spray of dilute sulfuric acid and/or water. This acid and/or water is filtered; the solid residue contains most of the volatile components of the concentrates to be roasted.
EC / List no:
309-609-9
| CAS no:
100403-63-2
2-[2-[(3-ethyl-5-methyl-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]-5,6-dimethyl-3-(3-sulphonatopropyl)benzoselenazolium
EC / List no:
254-733-8
| CAS no:
39981-05-0
5-Methoxy-2-((5-methyl-3-(3-sulfopropyl)-2(3H)-benzoselenazolylidene)methyl)-3-(3-sulfopropyl)benzoselenazolium, hydroxide, inner salt, sodium salt
EC / List no:
-
| CAS no:
70679-43-5
Benzenesulfonic acid, 2-formyl-, sodium salt, reaction products with disodium selenite and potassium cyanide
EC / List no:
290-717-7
| CAS no:
90218-42-1
3-ethyl-2-[3-(3-ethyl-3H-benzoselenazol-2-ylidene)isobut-1-enyl]benzoselenazolium iodide
EC / List no:
230-767-9
| CAS no:
7310-87-4
3-ethyl-2-methylbenzoselenazolium 4-methylbenzenesulphonate
EC / List no:
255-815-6
| CAS no:
42423-89-2
Ethyl 1-ethyl-2-[2-[(3-ethyl-5,6-dimethyl-3H-benzoselenazol-2-ylidene)methyl]-1-butenyl]naphtho[1,2-d]thiazolium sulphate
EC / List no:
285-275-7
| CAS no:
85050-02-8
2-[2-[(3-ethyl-5,6-dimethyl-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]-6-methoxy-5-methyl-3-(3-sulphonatopropyl)benzoselenazolium
EC / List no:
299-206-3
| CAS no:
93857-70-6
3-ethyl-2-[[1-ethyl-4-[(3-ethyl-3H-benzoselenazol-2-ylidene)ethylidene]-5-oxo-3-phenylimidazolidin-2-ylidene]methyl]benzoselenazolium iodide
EC / List no:
300-877-2
| CAS no:
93964-28-4
Benzoselenazolium, 2-methyl-3-(3-sulfopropyl)-, hydroxide, inner salt
EC / List no:
-
| CAS no:
29680-54-4
3-ethyl-2-[3-(3-ethyl-3H-benzoselenazol-2-ylidene)-2-methylprop-1-enyl]benzoselenazolium bromide
EC / List no:
246-408-4
| CAS no:
24687-31-8
2-[2-[(3-ethyl-6-methoxy-5-methyl-(3H)-benzoselenazol-2-ylidene)methyl]-1-butenyl]-1-(3-sulphonatopropyl)naphth[1,2-d]oxazolium
EC / List no:
303-334-8
| CAS no:
94166-38-8
3-ethyl-2-[3-(3-ethyl-3H-benzoselenazol-2-ylidene)prop-1-enyl]benzoselenazolium iodide
EC / List no:
213-882-9
| CAS no:
1049-38-3
1-ethyl-2-[[3-(4-sulphonatobutyl)-2-benzoselenazolinylidene]methyl]quinolinium
EC / List no:
251-912-2
| CAS no:
34276-89-6
3-ethyl-2-[2-[(3-ethyl-5-methoxy-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]-5,6-dimethylbenzoselenazolium iodide
EC / List no:
299-223-6
| CAS no:
93857-89-7
3-ethyl-2-[2-[(3-ethyl-3H-benzoselenazol-2-ylidene)methyl]but-1-enyl]benzoselenazolium iodide
EC / List no:
213-002-3
| CAS no:
909-64-8
2-[2-[[5,6-dimethoxy-3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene]methyl]but-1-enyl]-3-ethyl-5-methoxybenzoxazolium
EC / List no:
266-543-2
| CAS no:
67014-91-9
Slimes and Sludges, copper conc. roasting off gas scrubbing, lead-mercury-selenium-contg.
The product obtained by the purification of copper ore concentrate roasting offgas. Composed primarily of lead, mercury and selenium.
EC / List no:
310-062-3
| CAS no:
102110-61-2
Cadmium selenide (CdSe), solid soln. with cadmium sulfide, zinc selenide and zinc sulfide, gold and manganese-doped
EC / List no:
309-900-0
| CAS no:
101357-03-3
1-ethyl-2-[(3-ethyl-3H-benzoselenazol-2-ylidene)methyl]-6-methylquinolinium iodide
EC / List no:
264-536-9
| CAS no:
63870-48-4
5-chloro-3-ethyl-2-[[1-ethyl-4-[(3-ethyl-3H-benzoselenazol-2-ylidene)ethylidene]-5-oxo-3-phenylimidazolidin-2-ylidene]methyl]benzothiazolium iodide
EC / List no:
298-771-3
| CAS no:
93839-00-0
2-[2-chloro-2-(2-thienyl)vinyl]-3-ethyl-5-methoxybenzoselenazolium chloride
EC / List no:
270-258-9
| CAS no:
68413-87-6
Benzoselenazolium, 5-methoxy-2-methyl-3-(4-sulfobutyl)-, hydroxide, inner salt
EC / List no:
-
| CAS no:
63815-76-9
Cadmium selenide (CdSe), solid soln. with cadmium sulfide
EC / List no:
275-290-7
| CAS no:
71243-75-9
Benzoselenazolium, 3-ethyl-5-methoxy-2-(2-(methylthio)-1-buten-1-yl)-, iodide (1:1)
EC / List no:
-
| CAS no:
63816-17-1
3-ethyl-2-[3-(3-ethylthiazolidin-2-ylidene)prop-1-enyl]benzoselenazolium iodide
EC / List no:
251-594-5
| CAS no:
33609-19-7
1-ethyl-4-[(3-ethyl-3H-benzoselenazol-2-ylidene)methyl]quinolinium iodide
EC / List no:
282-556-6
| CAS no:
84255-09-4
|
-
|
-
|
Acute Tox. 3; STOT RE 2 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
68130-19-8
|
Carc. 1A; Repr. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
-
|
37296-97-2
|
STOT RE 2 |
|||
|
253-461-7
|
37321-15-6
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
|||
|
206-991-8
|
409-21-2
|
Carc. 1B |
|||
|
-
|
308076-74-6
|
Carc. 1B |
|||
|
233-054-0
|
10026-04-7
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
605-752-9
|
175217-20-6
|
STOT RE 2 |
|||
|
231-853-9
|
7761-88-8
|
Ox. Sol. 2; Skin Corr. 1B |
|||
|
603-404-0
|
130328-20-0
|
Repr. 2; Skin Irrit. 2; Eye Dam. 1 |
|||
|
204-535-2
|
122-34-9
|
Carc. 2 |
|||
|
213-801-7
|
1014-70-6
|
Acute Tox. 4 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.
|
292-659-8
|
90669-77-5
|
Carc. 1B |
||
|
A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.
|
309-723-9
|
100684-49-9
|
Carc. 1B |
||
|
A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.
|
292-660-3
|
90669-78-6
|
Carc. 1B |
||